Why the study?
Advanced arrhythmogenic right ventricular cardiomyopathy carries a high risk of malignant ventricular arrhythmias and end-stage heart failure, but the prognostic role of right atrial mechanics quantified by cardiac magnetic resonance imaging remained largely unexplored.
Does cardiac magnetic resonance-derived right atrial reservoir strain predict end-stage heart failure and malignant ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy?
Cohort (n=316)
Does cardiac magnetic resonance-derived right atrial reservoir strain predict end-stage heart failure and malignant ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy?
CMR-derived right atrial reservoir strain independently predicts end-stage heart failure and malignant ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy, adding incremental prognostic value beyond conventional risk markers.
Answers are grounded in this paper and cite their sources.
May refine risk stratification in arrhythmogenic right ventricular cardiomyopathy; hypothesis-generating and requires prospective validation before clinical use.
Background Advanced arrhythmogenic right ventricular cardiomyopathy is associated with a high risk of malignant ventricular arrhythmias (MVA) and end‐stage heart failure (HF). However, the prognostic role of right atrial (RA) mechanics, as quantified by cardiac magnetic resonance imaging (CMR), remains largely unexplored. Methods Consecutive patients with arrhythmogenic right ventricular cardiomyopathy undergoing CMR between 2014 and 2021 were retrospectively included. Demographics, clinical history, and strain parameters were collected. The primary clinical end points were end‐stage HF and MVA. Results A total of 316 patients (mean age 38±15 years; 66.1% men) were included. Over a median follow‐up of 5.3 years, 49 developed end‐stage HF and 103 experienced MVA outcomes. Multivariable Cox and Fine‐Gray models showed that impaired RA reservoir strain was an independent predictor of end‐stage HF (hazard ratio [HR] 0.92, 95% CI 0.89–0.96, P <0.001) and MVA outcomes (subdistribution hazard ratio (sHR) 0.98, 95% CI 0.96–0.99, P =0.025), with added prognostic value beyond clinical and imaging variables, improving the C‐statistic to 0.84 and 0.70, respectively. Kaplan–Meier survival curves indicated that RA reservoir strain <18.6% was associated with higher end‐stage HF risk, consistent across subgroups regardless of left ventricular involvement (both log‐rank P <0.05). The association between RA reservoir strain <23.0% and MVA was significant in the overall cohort ( P <0.001) and in patients without left ventricular involvement ( P =0.002), but not in those with left ventricular involvement ( P =0.08). Conclusions Lower cardiac magnetic resonance‐derived RA reservoir strain was independently associated with end‐stage HF and MVA in arrhythmogenic right ventricular cardiomyopathy and provided incremental prognostic value beyond conventional risk markers. These findings support RA mechanics as a potential complementary component of multichamber CMR risk assessment, pending external validation.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) conducted a cohort in Arrhythmogenic right ventricular cardiomyopathy (n=316). Impaired right atrial reservoir strain on cardiac magnetic resonance vs. Higher right atrial reservoir strain was evaluated on End-stage heart failure and malignant ventricular arrhythmias (HR 0.92, 95% CI 0.89-0.96, p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: